Cytokine release syndrome (CRS) is a phenomenon of immune hyperactivation described in
the setting of cellular and bispecific T‐cell engaging immunotherapy. Checkpoint blockade …

In both cardiovascular disease and cancer, there are established sex-based differences in
prevalence and outcomes. Males and females may also differ in terms of risk of cardiotoxicity …

Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …

Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of
hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study …

Mucosal barrier injury laboratory-confirmed bloodstream infections (MBI-LCBIs) lead to
significant morbidity, mortality, and healthcare resource utilization in hematopoietic stem cell …

Some patients with high ST2 levels, a marker for endothelial injury that is seen in graft-
versus-host disease (GVHD), may have a response to treatment aimed at thrombotic …

Prolonged thrombocytopenia after hematopoietic stem cell transplantation (HSCT) is a strong
risk factor for transplantation-related morbidity and mortality, and no standard treatment …

Purpose Today, male and female adult and pediatric cancer patients, individuals transitioning
between gender identities, and other individuals facing health extending but fertility …

Importance Patients undergoing hematopoietic stem cell transplant (HSCT) are at risk for
bloodstream infection (BSI) secondary to translocation of bacteria through the injured mucosa, …

There is marked paucity of data regarding late effects in adolescents and young adults (AYAs)
who undergo myeloablative conditioning (MAC) allogeneic hematopoietic cell …